Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | CYP2C8 | P10632 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL585042 | 0.85 | TLR8 (0.36) | — | |
| SCHEMBL7180826 | 0.79 | MEN1 (0.34) | CYP3A4 | |
| SCHEMBL6003914 | 0.78 | ALOX5 (0.31) | CYP2D6CYP2C9CYP2C19 | |
| Hydrochloric Acid SCHEMBL27872843 | 0.77 | ALOX5 (0.30) | CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL585686 | 0.75 | PTGS2 (0.35) | CYP3A4 | |
| SCHEMBL1772836 | 0.75 | ALOX5 (0.30) | CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL17681582 | 0.75 | CASP3 (0.42) | — | |
| SCHEMBL17681578 | 0.75 | CASP3 (0.42) | — | |
| SCHEMBL7262706 | 0.74 | TLR8 (0.32) | — | |
| SCHEMBL7717025 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6602998-B2 | Connector for energy transfer devices; photosynthesis sytems; solar cells | NARA INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) | 2003-08-05 | — | — | US | disclosed |
| US-20010027252-A1 | Novel mercapto-substitued imidazolylporphyrin metal complex monomer, polymer having the same as a repeating unit and method of preparing the same | NARA INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) | 2001-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010027252-A1 | Novel mercapto-substitued imidazolylporphyrin metal complex monomer, polymer having the same as a repeating unit and method of preparing the same | AP1M1, MGAT3, AP3M1 | GHSR 2271/4885CYP1A2 1076/4885CYP2E1 523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.